Impact of transcription factor profile and chromatin conformation on human hepatocyte CYP3A gene expression

Drug Metabolism and Disposition

Volumn 33, Issue 2, 2005, Pages 233-242

  Phillips, Anna ^a   Hood, Steve R ^b   Gibson, G Gordon ^a   Plant, Nick J ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; DEXAMETHASONE; OVALBUMIN; PHENOBARBITAL; PREGNANE 16ALPHA CARBONITRILE; PREGNANE DERIVATIVE; PREGNANE X RECEPTOR; RIFAMPICIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CHROMATIN; CHROMATIN STRUCTURE; DOSE RESPONSE; GENE EXPRESSION; GENE INTERACTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CHROMATIN; CYTOCHROME P-450 CYP3A; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; OXIDOREDUCTASES, N-DEMETHYLATING; PROTEIN CONFORMATION; TRANSCRIPTION FACTORS;

GALLUS GALLUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 13444292820     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.001461     Document Type: Article

References (44)

1. Alvarez M, Rhodes SJ, and Bidwell JP (2003) Context-dependent transcription: all politics is local. Gene 313:43-57.
2. Ashe HL, Monks J, Wijgerde M, Fraser P, and Proudfoot NJ (1997) Intergenic transcription and transinduction of the human beta-globin locus. Genes Dev 11:2494-2509.
3. Barwick JL, Quattrochi LC, Mills AS, Potenza C, Tukey RH, and Guzelian PS (1996) Transspecies gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10-16.
4. Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12:142-148.
5. Binda D, Lasserre-Bigot D, Bonet A, Thomassin M, Come MP, Guinchard C, Bars R, Jacqueson A, and Richert L (2003) Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME. Toxicol In Vitro 17:59-67.
6. Bombail V, Taylor K, Gibson G, and Plant N (2004) Role of Sp1, C/EBPα, HNF3 and PXR in the basal and xenobiotic-mediated regulation of the CYP3A4 gene. Drug Metab Dispos 32:525-535.
7. Boustead JN, Stadelmaier BT, Eeds AM, Wiebe PO, Svitek CA, Oeser JK, and O'Brien RM (2003) Hepatocyte nuclear factor-4alpha mediates the stimulatory effect of peroxisome proliferator-activated receptor gamma co-activator-1alpha (PGC-1alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells. Biochem J 369:17-22.
8. Brandon EF, Raap CD, Meijerman I, Beijnen JH, and Schellens JH (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233-246.
9. Coulson MD, Gibson GG, Plant N, Hammond T, and Graham M (2003) Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis. Toxicol Appl Pharmacol 192:154-163.
10. Dillon N and Festenstein R (2002) Unraveling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet 18:252-258.
11. Domanski T, Finta C, Halpert J, and Zaphiropoulos P (2001) cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol 59:386-392.
12. El-Sankary W, Gibson GG, Ayrton A, and Plant N (2001) Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers. Drug Metab Dispos 29:1499-1504.
13. El-Sankary W, Plant N, and Gibson G (2000) Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: role of the glucocorticoid and pregnane X receptors. Drug Metab Dispos 28:493-496.
14. Esteller M (2003) Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 532:39-49.
15. Francis GA, Fayard E, Picard F, and Auwerx J (2003) Nuclear receptors and the control of metabolism. Annu Rev Physiol 65:261-311.
16. Gibson G, Plant N, Swales K, Ayrton A, and El-Sankary W (2002) Receptor-dependent transcriptional activation of cytochrome P450 3A genes: induction mechanisms, species differences and inter-individual variation in man. Xenobiotica 32:165-206.
17. Gonzalez MM and Carlberg C (2002) Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. J Biol Chem 277:18501-18509.
18. Hakkola J, Raunio H, Purkunen R, Saarikoski S, Vahakangas K, Pelkonen O, Edwards RJ, Boobis AR, and Pasanen M (2001) Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 80:193-201.
19. Horikawa I and Barrett JC (2003) Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24:1167-1176.
20. Hukkanen J, Mantyla M, Kangas L, Wirta P, Hakkola J, Paakki P, Evisalmi S, Pelkonen O, and Raunio H (1998) Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium. Pharmacol Toxicol 82:93-97.
21. Huss J and Kasper C (2000) Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors. Mol Pharmacol 58:48-57.
22. Kioussis D and Festenstein R (1997) Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr Opin Genet Dev 7:614-619.
23. Krusekopf S, Roots I, Hildebrandt AG, and Kleeberg U (2003) Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobiotics. Xenobiotica 33:107-118.
24. Miyajima N, Kadowaki Y, Fukushige S, Shimizu S, Semba K, Yamanashi Y, Matsubara K, Toyoshima K, and Yamamoto T (1988) Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res 16:11057-11074.
25. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127.
26. Moreira JM, Scheipers P, and Sorensen P (2003) The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer 3:30-48.
27. Nakabayashi H, Taketa K, Miyano K, Yamane T, and Sato J (1982) Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 42:3858-3863.
28. Oesterheld JR (1998) A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharmacol 8:161-174.
29. Pascussi J-M, Drocourt L, Fabre J-M, Maurel P, and Vilarem M-J (2000) Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor. Mol Pharmacol 58:361-372.
30. Pfahl M, Apfel R, Bendick I, Fanjul A, Graupner G, and Lee MO (1994) Nuclear retinoid receptors and their mechanism of action. Vitam Horm 49:327-382.
31. Pipaon C, Tsai SY, and Tsai MJ (1999) COUP-TF upregulates NGF1-A gene expression through an Sp1 binding site. Mol Cell Biol 19:2734-2745.
32. Plant N (2004) Strategies for using in vitro screens in drug metabolism. Drug Discov Today 9:328-336.
33. Raucy JL (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31:533-539.
34. Rigaud G, Roux J, Pictet R, and Grange T (1991) In vivo footprinting of rat TAT gene-dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67:977-986.
35. Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, Li D, and Guzelian PS (1993) Regulation of human liver cytochromes P-450 in Family 3A in primary and continuous-culture of human hepatocytes. Hepatology 18:1254-1262.
36. Shenoy SD, Spencer TA, Mercer-Haines NA, Alipour M, Gargano MD, Runge-Morris M, and Kocarek TA (2004) CYP3A induction by liver X receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos 32:66-71.
37. Song X, Xie M, Zhang H, Li Y, Sachdeva K, and Yan B (2004) The pregnane X receptor binds to response elements in a genomic context-dependent manner and PXR activator rifampicin selectively alters the binding among target genes. Drug Metab Dispos 32:35-42.
38. Stevens JC, Hines RN, Gu CG, Koukouritaki SB, Manro JR, Tandler PJ, and Zaya MJ (2003) Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307:573-582.
39. Swales KE, Plant N, Ayrton A, Hood S, and Gibson G (2003) Relative receptor expression is a determinant in xenobiotic-mediated CYP3A induction in rat and human cells. Xenobiotica 33:703-716.
40. Thomassin H, Flavin M, Espinas ML, and Grange T (2001) Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO (Eur Mol Biol Organ) J 20:1974-1983.
41. Tsai SY and Tsai M-J (1997) Chicken ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr Rev 18:229-240.
42. Usui T, Saitoh Y, and Komada F (2003) Induction of CYP3As in HepG2 cells by several drugs-association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull 26:510-517.
43. Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, and Wrighton SA (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5 and CYP3A7. Drug Metab Dispos 30:883-891.
44. Xie W, Barwick J, Downes M, Blumberg B, Simon C, Nelson M, Neuschwander-Tetri B, Brunt E, Guzelian P, and Evans R (2000) Humanized xenobiotic in mice expressing nuclear receptor SXR. Nature (Lond) 406:435-438.